Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy

被引:19
作者
Huang, Guojun [1 ,2 ]
Liu, Lanlan [1 ,2 ]
Pan, Hong [1 ,2 ]
Cai, Lintao [1 ,2 ]
机构
[1] Chinese Acad Sci, Shenzhen Inst Adv Technol SIAT, CAS HK Joint Lab Biomat, Guangdong Key Lab Nanomed, Shenzhen 518055, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
基金
中国国家自然科学基金;
关键词
biomimetic active materials; cancer immunotherapy; immune regulation; immunogenic cell death; tumor immunogenicity; OUTER-MEMBRANE VESICLES; TUMOR-ASSOCIATED MACROPHAGES; VIRUS-BASED IMMUNOTHERAPY; DRUG-DELIVERY SYSTEMS; PHOTODYNAMIC THERAPY; ONCOLYTIC VIRUSES; DENDRITIC CELLS; NANOPARTICLES; COMBINATION; RADIOTHERAPY;
D O I
10.1002/smtd.202201412
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Despite immunotherapy emerging as a vital approach to improve cancer treatment, the activation of efficient immune responses is still hampered by immunosuppression, especially due to the low tumor immunogenicity. Immunogenic cell death (ICD) is a promising strategy to reshape the tumor microenvironment (TME) for achieving high immunogenicity. Various stimuli are able to effectively initiate their specific ICD by utilizing the corresponding ICD-inducer. However, the ICD-guided antitumor immune effects are usually impaired by various biological barriers and TME-associated immune resistance. Biomimetic active materials are being extensively explored as guided agents for ICD due to their unique advantages. In this review, two major strategies are systematically introduced that have been employed to exploit biomimetic active materials guided ICD for cancer immunotherapy, mainly including naive organism-derived nanoagents and engineered bioactive platforms. This review outlines the recent advances in the field at biomimetic active materials guided physiotherapy, chemotherapy, and biotherapy for ICD induction. The advances and challenges of biomimetic active materials guided ICD for cancer immunotherapy applications are further discussed in future clinical practice. This review provides an overview of the advances of biomimetic active materials for targeting immunoregulation and treatment and can contribute to the future of advanced antitumor combination therapy.
引用
收藏
页数:15
相关论文
共 140 条
[1]   The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence [J].
Barker, Holly E. ;
Paget, James T. E. ;
Khan, Aadil A. ;
Harrington, Kevin J. .
NATURE REVIEWS CANCER, 2015, 15 (07) :409-425
[2]   Combinatorial strategies for the induction of immunogenic cell death [J].
Bezu, Lucillia ;
Gomes-de-Silva, Ligia C. ;
Dewitte, Heleen ;
Breckpot, Karine ;
Fucikova, Jitka ;
Spisek, Radek ;
Galluzzi, Lorenzo ;
Kepp, Oliver ;
Kroemer, Guido .
FRONTIERS IN IMMUNOLOGY, 2015, 6
[3]   The determinants of tumour immunogenicity [J].
Blankenstein, Thomas ;
Coulie, Pierre G. ;
Gilboa, Eli ;
Jaffee, Elizabeth M. .
NATURE REVIEWS CANCER, 2012, 12 (04) :307-313
[4]   Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma [J].
Bommareddy, Praveen K. ;
Zloza, Andrew ;
Rabkin, Samuel D. ;
Kaufman, Howard L. .
ONCOIMMUNOLOGY, 2019, 8 (07)
[5]   Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer [J].
Cao, Haiqiang ;
Dan, Zhaoling ;
He, Xinyu ;
Zhang, Zhiwen ;
Yu, Haijun ;
Yin, Qi ;
Li, Yaping .
ACS NANO, 2016, 10 (08) :7738-7748
[6]   H2O2-Activatable and O2-Evolving Nanoparticles for Highly Efficient and Selective Photodynamic Therapy against Hypoxic Tumor Cells [J].
Chen, Huachao ;
Tian, Jiangwei ;
He, Weijiang ;
Guo, Zijian .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (04) :1539-1547
[7]   A Hybrid Eukaryotic-Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination [J].
Chen, Qi ;
Huang, Guojun ;
Wu, Wangteng ;
Wang, Jianwei ;
Hu, Jiawei ;
Mao, Jianming ;
Chu, Paul K. ;
Bai, Hongzhen ;
Tang, Guping .
ADVANCED MATERIALS, 2020, 32 (16)
[8]   Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy [J].
Chen, Qian ;
Chen, Jiawen ;
Yang, Zhijuan ;
Xu, Jun ;
Xu, Ligeng ;
Liang, Chao ;
Han, Xiao ;
Liu, Zhuang .
ADVANCED MATERIALS, 2019, 31 (10)
[9]   Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise [J].
Chen, Qian ;
Liu, Zhuang .
ADVANCED MATERIALS, 2016, 28 (47) :10557-10566
[10]   Nanoengineered CAR-T Biohybrids for Solid Tumor Immunotherapy with Microenvironment Photothermal-Remodeling Strategy [J].
Chen, Ze ;
Pan, Hong ;
Luo, Yingmei ;
Yin, Ting ;
Zhang, Baozhen ;
Liao, Jianhong ;
Wang, Mengmeng ;
Tang, Xiaofan ;
Huang, Guojun ;
Deng, Guanjun ;
Zheng, Mingbin ;
Cai, Lintao .
SMALL, 2021, 17 (14)